Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Medical Oncology. Found 29 abstracts

no pagination
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018 Jun;21(6):742-7.
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value Health. 2018 Jun;21(6):742-7.
Tetzlaff ED, Hylton HM, DeMora L, Ruth K, Wong YN. National Study of Burnout and Career Satisfaction Among Physician Assistants in Oncology: Implications for Team-Based Care. J Oncol Pract. 2018 Jan;14(1):e11-e22.   PMCID: PMC6528779
Dotan E. Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation. Surg Oncol Clin N Am. 2017 Oct;26(4):719-28.
Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MA, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson RH, Uzzo R, Russo P. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017 Feb 20;35(6):668-80.
Yoo SK, Ahmed AA, Ileto J, Zaorsky NG, Deville C, Holliday EB, Wilson LD, Jagsi R, Thomas CR. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015. Int J Radiat Oncol Biol Phys. 2017 Oct;99(2):280-5.
Olszanski AJ. Principles of immunotherapy. J Natl Compr Canc Netw. 2015 May;13(5 Suppl):670-2.
Hall MJ. Conflicted confidence: academic oncologists' views on multiplex pharmacogenomic testing. J Clin Oncol. 2014 May;32(13):1290-2.   PMCID: Comment
Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM. Micropapillary bladder cancer: current treatment patterns and review of the literature. Urol Oncol. 2014 Aug;32(6):826-32.   PMCID: PMC4687398
Engstrom PF. Physician burnout. J Natl Compr Canc Netw. 2013 Apr;11(4):502-4.   PMCID: Editorial
Miller SM, Roussi P, Daly MB, Scarpato J. New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res. 2010 Nov;16(21):5094-106.   PMCID: Pmc3107031
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10;27(23):3868-74.
Kaplan DJ, Crispen PL, Greenberg RE, Chen DY, Viterbo R, Buyyounouski MK, Horwitz EM, Uzzo RG. Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Urology. 2008 Sep;72(3):654-8.   PMCID: PMC2660570
Mehra R, Cohen RB, Harari PM. EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Current oncology reports. 2008 Mar;10(2):176-84.
Daly MB. Genetic screening and counseling for high-risk populations. Chang AE, Ganz P, Hayes D, Kinsella H, Pass H, Schiller J, Stone R, Strecher V, editors. New York, NY: Springer; 2006.
Jordan VC, Knudson AG. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspective. Oncology (Williston Park). 2006 May;20(6):553-62; discussion 567-8, 573, 577.
Levy MH, Back A, Bazargan S, Benedetti C, Billings JA, Block S, Bruera E, Carducci MA, Dy S, Eberle C, Foley KM, Harris JD, Knight SJ, Milch R, Rhiner M, Slatkin NE, Spiegel D, Sutton L, Urba S, Von Roenn JH, Weinstein SM, National Comprehensive Cancer N. Palliative care. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2006 Sep;4(8):776-818.
Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB. Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation. International journal of behavioral medicine. 2006 Jan;13(1):8-15.
von Mehren M. Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategies. Current oncology reports. 2006 May;8(3):192-7.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Anal canal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):510-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Medical Oncology

Medical Oncology Neoplasms therapy Female methods Male Antineoplastic Agents Treatment Outcome United States drug therapy trends diagnosis adverse effects Surveys and Questionnaires prevention & control pathology Combined Modality Therapy pc [Prevention & Control] tolerability drug safety Medical Education-Continuing Biomedical Research Job Satisfaction Evidence-Based Medicine patient-reported outcomes Professional Burnout economics antagonists & inhibitors Physicians Adult th [Therapy] etiology Immunotherapy Patient Education as Topic Critical Pathways United States Food and Drug Administration Radiation Oncology pharmacology therapeutic use Clinical Competence Drug Industry Patient Reported Outcome Measures Drug Delivery Systems 80 and over Aged statistics & numerical data Neoplasm Staging oncology psychology Drug-Related Side Effects and Adverse Reactions Pro-ctcae NIH Research Support-Extramural Patient Care Team standards Aged Cancer Oncology Smoking Cessation Directive Counseling Cystectomy epidemiology Age Factors Older cancer patients Middle Aged Choice Behavior surgery Communication Transitional Cell Carcinoma Review Non-US Gov't Research Support Breast Neoplasms Residence Characteristics Cost of Illness Carcinoma mortality Aging Physician's Role Piperazines Hormone Replacement Therapy Prostatectomy Pain Prostatic Neoplasms Survivors Palliative Care genetics Insurance Coverage biosynthesis drug effects Consultants Physician-Patient Relations Epidermal Growth Factor Receptor Micropapillary Radiotherapy Ovariectomy Survey Urinary Bladder Neoplasms Retrospective Studies Kidney Neoplasms Gastrointestinal Stromal Tumors ed [Education] Neoplasm Drug Resistance Conflict of Interest Protein Kinase Inhibitors Geriatrics immunology Health Facility Administrators mt [Methods] Health Insurance data Patient Selection Moscow di [Diagnosis] Adjuvant Chemotherapy enzymology organization & administration physiology Squamous Cell Carcinoma Drug Costs Salpingostomy Risk Factors radiotherapy Adaptive Immunity Vascular Endothelial Growth Factor Receptors Bladder cancer Physician's Practice Patterns Prostate-Specific Antigen utilization Survival Rate Confidence Intervals st [Standards] administration & dosage Family Medical Societies Smoking Interpersonal Relations Health Care Costs Research Subjects Decision Making Biomedical Technology Time Factors pa [Pathology] px [Psychology] Leadership Prostate Risk Reduction Behavior Physicians' Practice Patterns Neoplasm Metastasis complications Hormonal Antineoplastic Agents Industry Attitude of Health Personnel
Last updated on Friday, January 03, 2020